Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Coe

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|January 27, 2009
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effectHans Rollema, Victor Guanowsky, Yann S Mineur, et al.
Behavioural Pharmacology|May 14, 2011
α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like propertiesYann S Mineur, Emily B Einstein, Patricia A Seymour, et al.
Organic Letters|August 21, 2015
Access to Highly Substituted 7-Azaindoles from 2-Fluoropyridines via 7-Azaindoline IntermediatesPhilippe Nuhant, Christophe Allais, Ming Z Chen, et al.
Journal of the American Chemical Society|February 26, 2008
Structural and rate studies of the formation of substituted benzynesJason C Riggs, Antonio Ramirez, Matthew E Cremeens, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2005
Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitroR Scott Obach, Anne E Reed-Hagen, Suzanne S Krueger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 2010
Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in ratsSusmita Chatterjee, Pia Steensland, Jeffrey A Simms, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2019
High-Throughput Ligand Screening Enables the Enantioselective Conjugate Borylation of Cyclobutenones to Access Synthetically Versatile Tertiary CyclobutylboronatesHelen A Clement, Michele Boghi, Rory M McDonald, et al.
Organic Letters|December 15, 2006
Enantioselective synthesis of nicotinic receptor probe 7,8-difluoro-1,2,3,4,5,6- hexahydro-1,5-methano-3-benzazocineCrystal G Bashore, Michael G Vetelino, Michael C Wirtz, et al.
British Journal of Pharmacology|March 25, 2010
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependenceH Rollema, A Shrikhande, K M Ward, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|January 27, 2009
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effectHans Rollema, Victor Guanowsky, Yann S Mineur, et al.
Behavioural Pharmacology|May 14, 2011
α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like propertiesYann S Mineur, Emily B Einstein, Patricia A Seymour, et al.
Organic Letters|August 21, 2015
Access to Highly Substituted 7-Azaindoles from 2-Fluoropyridines via 7-Azaindoline IntermediatesPhilippe Nuhant, Christophe Allais, Ming Z Chen, et al.
Journal of the American Chemical Society|February 26, 2008
Structural and rate studies of the formation of substituted benzynesJason C Riggs, Antonio Ramirez, Matthew E Cremeens, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 14, 2005
Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitroR Scott Obach, Anne E Reed-Hagen, Suzanne S Krueger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 2010
Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in ratsSusmita Chatterjee, Pia Steensland, Jeffrey A Simms, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2019
High-Throughput Ligand Screening Enables the Enantioselective Conjugate Borylation of Cyclobutenones to Access Synthetically Versatile Tertiary CyclobutylboronatesHelen A Clement, Michele Boghi, Rory M McDonald, et al.
Organic Letters|December 15, 2006
Enantioselective synthesis of nicotinic receptor probe 7,8-difluoro-1,2,3,4,5,6- hexahydro-1,5-methano-3-benzazocineCrystal G Bashore, Michael G Vetelino, Michael C Wirtz, et al.
British Journal of Pharmacology|March 25, 2010
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependenceH Rollema, A Shrikhande, K M Ward, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
Pageof 4